153 related articles for article (PubMed ID: 27816772)
1. Biochemical and functional characterization of glycosaminoglycans released from degranulating rat peritoneal mast cells: Insights into the physiological role of endogenous heparin.
Lever R; Smailbegovic A; Riffo-Vasquez Y; Gray E; Hogwood J; Francis SM; Richardson NV; Page CP; Mulloy B
Pulm Pharmacol Ther; 2016 Dec; 41():96-102. PubMed ID: 27816772
[TBL] [Abstract][Full Text] [Related]
2. Locally available heparin modulates inflammatory cell recruitment in a manner independent of anticoagulant activity.
Lever R; Smailbegovic A; Page CP
Eur J Pharmacol; 2010 Mar; 630(1-3):137-44. PubMed ID: 20043903
[TBL] [Abstract][Full Text] [Related]
3. Mast cell glycosaminoglycans.
Mulloy B; Lever R; Page CP
Glycoconj J; 2017 Jun; 34(3):351-361. PubMed ID: 27900574
[TBL] [Abstract][Full Text] [Related]
4. Implications of Heparanase on Heparin Synthesis and Metabolism in Mast Cells.
Maccarana M; Jia J; Li H; Zhang X; Vlodavsky I; Li JP
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563215
[TBL] [Abstract][Full Text] [Related]
5. Dermatan sulfate is the predominant antithrombotic glycosaminoglycan in vessel walls: implications for a possible physiological function of heparin cofactor II.
Tovar AM; de Mattos DA; Stelling MP; Sarcinelli-Luz BS; Nazareth RA; Mourão PA
Biochim Biophys Acta; 2005 Apr; 1740(1):45-53. PubMed ID: 15878740
[TBL] [Abstract][Full Text] [Related]
6. Does heparin occur in mucosal mast cells of the rat small intestine?
Tas J; Berndsen RG
J Histochem Cytochem; 1977 Sep; 25(9):1058-62. PubMed ID: 71326
[TBL] [Abstract][Full Text] [Related]
7. Degradation of the heparin matrix of mast cell granules by cultured fibroblasts.
Atkins FM; Metcalfe DD
J Immunol; 1983 Sep; 131(3):1420-5. PubMed ID: 6886421
[TBL] [Abstract][Full Text] [Related]
8. Turkey intestine as a commercial source of heparin? Comparative structural studies of intestinal avian and mammalian glycosaminoglycans.
Warda M; Mao W; Toida T; Linhardt RJ
Comp Biochem Physiol B Biochem Mol Biol; 2003 Jan; 134(1):189-97. PubMed ID: 12524047
[TBL] [Abstract][Full Text] [Related]
9. Latexin, a carboxypeptidase A inhibitor, is expressed in rat peritoneal mast cells and is associated with granular structures distinct from secretory granules and lysosomes.
Uratani Y; Takiguchi-Hayashi K; Miyasaka N; Sato M; Jin M; Arimatsu Y
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):817-26. PubMed ID: 10698712
[TBL] [Abstract][Full Text] [Related]
10. Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties.
Harris N; Kogan FY; Il'kova G; Juhas S; Lahmy O; Gregor YI; Koppel J; Zhuk R; Gregor P
Biochim Biophys Acta; 2014 Jan; 1840(1):245-54. PubMed ID: 24060749
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of thrombosis in melanoma allografts in mice by endogenous mast cell heparin.
Samoszuk M; Corwin M; Yu H; Wang J; Nalcioglu O; Su MY
Thromb Haemost; 2003 Aug; 90(2):351-60. PubMed ID: 12888884
[TBL] [Abstract][Full Text] [Related]
12. Heparin-like glycosaminoglycans inhibit leukocyte adhesion to endotoxin-activated human vascular endothelial cells under nonstatic conditions.
Kitamura N; Yamaguchi M; Shimabukuro K; Miyasaka M; Nakano H; Kumada K
Eur Surg Res; 1996; 28(6):428-35. PubMed ID: 8954319
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory properties of a heparin-like glycosaminoglycan with reduced anti-coagulant activity isolated from a marine shrimp.
Brito AS; Arimatéia DS; Souza LR; Lima MA; Santos VO; Medeiros VP; Ferreira PA; Silva RA; Ferreira CV; Justo GZ; Leite EL; Andrade GP; Oliveira FW; Nader HB; Chavante SF
Bioorg Med Chem; 2008 Nov; 16(21):9588-95. PubMed ID: 18835720
[TBL] [Abstract][Full Text] [Related]
14. The mast cell/heparin paradox.
Jaques LB; Mahadoo J; Riley JF
Lancet; 1977 Feb; 1(8008):411-3. PubMed ID: 65521
[TBL] [Abstract][Full Text] [Related]
15. Immunologic release of heparin from purified rat peritoneal mast cells.
Yurt RW; Leid RW; Spragg J; Austen KF
J Immunol; 1977 Apr; 118(4):1201-7. PubMed ID: 321687
[TBL] [Abstract][Full Text] [Related]
16. Glycosaminoglycans in rat mucosal mast cells.
Enerbäck L; Kolset SO; Kusche M; Hjerpe A; Lindahl U
Biochem J; 1985 Apr; 227(2):661-8. PubMed ID: 4004785
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical localization of heparin in secretory granules of rat peritoneal mast cells using a monoclonal anti-heparin antibody (ST-1).
Oliani SM; Freymüller E; Takahashi HK; Straus AH
J Histochem Cytochem; 1997 Feb; 45(2):231-5. PubMed ID: 9016312
[TBL] [Abstract][Full Text] [Related]
18. Glycosaminoglycans and the regulation of allergic inflammation.
Rose MJ; Page C
Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):221-5. PubMed ID: 15446270
[TBL] [Abstract][Full Text] [Related]
19. Glycosaminoglycan profiles in cloned granulated lymphocytes with natural killer function and in cultured mast cells: their potential use as biochemical markers.
Bland CE; Rosenthal KL; Pluznik DH; Dennert G; Hengartner H; Bienenstock J; Metcalfe DD
J Immunol; 1984 Apr; 132(4):1937-42. PubMed ID: 6421930
[TBL] [Abstract][Full Text] [Related]
20. Incorporation, intracellular trafficking and processing of extracellular heparanase by mast cells: Involvement of syndecan-4-dependent pathway.
Higashi N; Waki M; Sudo Y; Suzuki S; Oku T; Tsuiji M; Tsuji T; Miyagishi M; Takahashi K; Nakajima M; Irimura T
Biochem Biophys Res Commun; 2018 Sep; 503(4):3235-3241. PubMed ID: 30149916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
